FDA Approved: ROFLUMILAST — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Novadoz Pharmaceuticals LLC's original application for roflumilast, enabling a generic version of the COPD medication to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

ORIG AP for ROFLUMILAST (ROFLUMILAST)